Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 47 citing articles:

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 64
Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
Lluís Rusiñol, L. Puig
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3391-3391
Open Access | Times Cited: 38
The role of Janus kinase signaling in the pathology of atopic dermatitis
Emma Guttman‐Yassky, Alan D. Irvine, Patrick M. Brunner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1394-1404
Open Access | Times Cited: 34
Itch and Janus Kinase Inhibitors
Yujin Han, Yu Ri Woo, Sang Hyun Cho, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv00869-adv00869
Open Access | Times Cited: 31
Challenges and Future Trends in Atopic Dermatitis
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 28
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
Alexa B. Kimball, Elena Peeva, Seth Forman, et al.
NEJM Evidence (2024) Vol. 3, Iss. 3
Closed Access | Times Cited: 13
Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives
Ashutosh Pareek, Lipika Kumari, Aaushi Pareek, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 425-425
Open Access | Times Cited: 12
Topical anti-inflammatory treatments for eczema: network meta-analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 8
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access | Times Cited: 1
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study
Megan N. Landis, Stacy Smith, Gabriel Berstein, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 1, pp. 33-41
Open Access | Times Cited: 19
Topical Treatments in Atopic Dermatitis: An Expansive Review
Michelle Lazar, Aurore D. Zhang, Neelam A. Vashi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2185-2185
Open Access | Times Cited: 5
The future of topical JAK inhibitors in the treatment of atopic dermatitis
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Topical treatments in special populations of atopic dermatitis – Chinese perspective
Huaying Ruan, Xiaoxia Zhu, Suling Xu, et al.
Expert Review of Clinical Immunology (2025), pp. 1-10
Closed Access
Therapeutic Inhibition of the JAK-STAT pathway in the treatment of Inflammatory Bowel Disease.
Zihan Chen, Ping Jiang, Dan Su, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 1-15
Closed Access | Times Cited: 4
Novel Therapeutic Strategies in the Topical Treatment of Atopic Dermatitis
Lorenzo Maria Pinto, Andrea Chiricozzi, Laura Calabrese, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2767-2767
Open Access | Times Cited: 17
Emerging role of topical Janus kinase inhibitors in dermatological disorders: a review
Sunil Dogra, Apoorva Sharma, Hitaishi Mehta, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 10, pp. 1102-1112
Closed Access | Times Cited: 8
Emerging treatments for itch in atopic dermatitis: A review
Angelina Labib, Teresa Ju, Gil Yosipovitch
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 2, pp. 338-344
Closed Access | Times Cited: 7
Novel Topical Treatments for Itch
Rami H. Mahmoud, Omar Mahmoud, Georgia Biazus Soares, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 4, pp. 829-840
Open Access | Times Cited: 2
Current and emerging drugs for the treatment of pruritus: an update of the literature
Rami H. Mahmoud, Sarah G Brooks, Gil Yosipovitch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 655-672
Closed Access | Times Cited: 2
The Future of Atopic Dermatitis Treatment
Katie Lovell, Nupur Patel, Saroja Rao, et al.
Advances in experimental medicine and biology (2024), pp. 227-244
Closed Access | Times Cited: 2
Treatment of Atopic Dermatitis in Children
Faten Sid Idris
Cureus (2024)
Open Access | Times Cited: 2
Recent advances in immunomodulators for atopic dermatitis
Hyun Jin Yim, Tiffany Jean, Peck Y. Ong
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 6, pp. 671-679
Closed Access | Times Cited: 6
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig Model
Manfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.
Pharmaceutical Research (2023) Vol. 41, Iss. 2, pp. 223-234
Open Access | Times Cited: 4
Topical Prescription Management
Katie Lovell, Bradley G. Ackerson, Ryan K. Thorpe, et al.
Advances in experimental medicine and biology (2024), pp. 117-129
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top